2011•China Medical HeraldRequires access

Clinical efficacy of Low-molecular-weight Heparin Sodium combined Aspirin in the treatment of unstable angina pectoris

Ping Xie

Abstract

Objective: To observe the clinical efficacy of Low-molecular-weight Heparin Sodium combined Aspirin in the treatment of unstable angina pectoris.Methods: 67 cases of patients with unstable angina pectoris were randomly divided into control group(34 cases) and treatment group(33 cases).The control group was received Aspirin for 1 week.The treatment group was received Low-molecular-weight Heparin Sodium for 1 week based on the control group.Results: The total effective rate of treatment group was 96.96% and was significantly higher than that of control group(76.47%)(P0.05).Conclusion: Low-molecular-weight Heparin Sodium combined with Aspirin is effective and safe in the treatment of unstable angina pectoris.

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Medicine, Aspirin, Low molecular weight heparin, Unstable angina, Heparin, Angina, Clinical efficacy, Heparin sodium